Market Mover: HTG Molecular Diagnostics (HTGM) Gains at Midday August 5

Equities Staff  |

Today HTG Molecular Diagnostics Inc (NASDAQ: HTGM) is trading 11.22% up.

The latest price, as of 11:57:32 est, was $1.19. HTG Molecular Diagnostics has climbed $0.12 in trading today.

236,579 shares have exchanged hands.

As of the previous close, HTG Molecular Diagnostics has moved YTD 77.31%. The company expects its next earnings on 2022-08-11.

For technical charts, analysis, and more on HTG Molecular Diagnostics visit the company profile.

About HTG Molecular Diagnostics Inc

HTG Molecular Diagnostics Inc. is focused on NGS-based molecular profiling. The Company's proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG's customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Its mission is to empower precision medicine.

To get more information on HTG Molecular Diagnostics Inc and to follow the company's latest updates, you can visit the company's profile page here: HTG Molecular Diagnostics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content